Chitaru Kurihara, MD

Research Project:
Mechanisms of Chronic Allograft Dysfunction After Lung Transplant

Grant Awarded:

Catalyst Award

Research Topics:

biomarkers
combination therapies experimental therapeutics
immunology immunotherapy
lung transplantation

While lung transplantation is a life-saving treatment for a variety of end-stage lung diseases, long-term outcomes of patients undergoing this intervention are limited due to the development of chronic lung allograft dysfunction (CLAD). This is a severe lung disease where the immune system attacks the airways of the lungs, also known as chronic rejection. We will determine whether drugs that we have shown reduce the risk of early graft injury, can reduce the risk of CLAD by reducing precluding normal repair in the lung.

Page last updated: October 3, 2023

Join the Patient & Caregiver Network

End Youth Vaping

10 Tips to Protect Yourself from Unhealthy Air

State of the Air Key Findings

Become an Advocate

Events Near You

Chitaru Kurihara, MD

A Breath of Fresh Air in Your Inbox

Thank You!

Make a Donation

Become a Lung Health Insider

Select Your Location

Change Language

Lung HelpLine

1-800-LUNG-USA